Burkhard Blank
2016
In 2016, Burkhard Blank earned a total compensation of $3.5M as Chief Medical Officer at Acorda Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $245,175 |
|---|---|
| Option Awards | $1,133,424 |
| Salary | $835,500 |
| Stock Awards | $1,299,500 |
| Other | $7,950 |
| Total | $3,521,549 |
Blank received $1.3M in stock awards, accounting for 37% of the total pay in 2016.
Blank also received $245.2K in non-equity incentive plan, $1.1M in option awards, $835.5K in salary and $8K in other compensation.
Rankings
In 2016, Burkhard Blank's compensation ranked 2,620th out of 14,075 executives tracked by ExecPay. In other words, Blank earned more than 81.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,620 out of 14,075 | 81st |
Division Manufacturing | 897 out of 5,489 | 84th |
Major group Chemicals And Allied Products | 262 out of 1,895 | 86th |
Industry group Drugs | 189 out of 1,538 | 88th |
Industry Biological Products, Except Diagnostic Substances | 42 out of 279 | 85th |
Source: SEC filing on April 21, 2017.
Blank's colleagues
We found five more compensation records of executives who worked with Burkhard Blank at Acorda Therapeutics in 2016.
2016
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2016
Jane Wasman
Acorda Therapeutics
General Counsel
2016
Andrew Hindman
Acorda Therapeutics
Chief Business Development Officer
2016
Michael Rogers
Acorda Therapeutics
Chief Financial Officer
2016
David Lawrence
Acorda Therapeutics
Chief, Business Operations and Principal Accounting Officer
News
Acorda Therapeutics CEO Ron Cohen's 2021 pay rises 9% to $1.6M
April 28, 2022
Acorda Therapeutics CEO Ron Cohen's 2020 pay falls 26% to $1.5M
April 23, 2021
Acorda Therapeutics General Counsel Jane Wasman's 2019 pay jumps 67% to $2.4M
April 28, 2020
Acorda Therapeutics CEO Ron Cohen's 2018 pay rises 20% to $2.4M
April 26, 2019